Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 819 results for "pfizer drugmaker pfizer"

Pfizer to launch cheaper version of J&J immune drug Remicade

Could Pfizer's at-risk Inflectra launch set a biosimilars prec...

Good news for biosimilar drugmakers: Pfizer's decision to launch its Remicade knockoff at-risk may make their own rollouts more secure. With U.S. biosimilars law taking shape in real time, the legal back-and-forthbetween the New York drugmaker ... FiercePharma, 1 day ago

110 images for pfizer drugmaker pfizer

San Francisco, 1 week ago
Town Hall, 1 week ago, 4 weeks ago
Financial Express, 2 weeks ago
Business Insider, 2 weeks ago
Reuters India, 3 weeks ago
Free Malaysia Today, 2 weeks ago, 1 week ago
CTV News, 4 weeks ago
Irish Times, 4 weeks ago
Investor's Business Daily

Pfizer Will Likely Overpay For M&A, After Allergan Flop: Jefferies

No. 2 drugmaker Pfizer ( PFE ) could become acquisitive after its decision not to break up the company, but it will likely overpay for those M&A assets, said Jefferies analyst Jeffrey Holford as he downgraded Pfizer stock Thursday, citing a lack of ...
 Investor's Business Daily1 week ago Deal-hungry Pfizer will likely overpay for M&A, analyst predicts  FiercePharma1 week ago Health news Drugmaker Pfizer decides not to break up business  Pharmacy Choice3 weeks ago Pfizer will not split into two firms  Kazakh TV3 weeks ago

[$$] Pfizer vows to persist in court battle over Lyrica

US drugmaker Pfizer plans to continue a legal battle with rival Actavis over the way its blockbuster drug Lyrica is sold in the UK after the Court of Appeal on Thursday rejected a claim of patent
 Yahoo! Finance1 week ago
Business Recorder

Pfizer loses Lyrica patent appeal in U.K., vows to appeal

Pfizer's divide-and-conquer approach to Lyrica in the U.K. just hit a wall. The Court of Appeal upheld a ruling that struck downkey patent claims on Lyrica and cleared Actavis generic of infringing it. The closely watched case centered on a ...
 FiercePharma1 week ago Pfizer loses appeal in UK patent case over use of Lyrica drug for pain  Sharenet1 week ago UPDATE 1-Pfizer loses appeal in UK patent case over use of Lyrica drug for pain  Business Insider1 week ago Pfizer to sell therapy unit  The Gulf Today2 weeks ago
4 Traders

Pfizer says to seek more modern Manhattan headquarters

Oct 6 (Reuters) - Pfizer Inc, the largest U.S. drugmaker, said it aims to sell its New York City world headquarters buildings in midtown Manhattan by the end of 2017 and to move into more modern Manhattan facilities no sooner than the first half of ...
 Yahoo! Finance2 weeks ago Pfizer to seek more modern headquarters in Manhattan  4 Traders2 weeks ago Wanted: Pfizer Seeks Shiny, New Headquarters in the Big Apple  BioSpace2 weeks ago Pfizer plots move to new-and-improved HQ in Manhattan  FiercePharma2 weeks ago

[$$] Allergan steps out of Pfizer ashes with $7bn of deals

Allergan, the drugmaker best known for its Botox wrinkle treatment, has been engaged in a furious bout of dealmaking over the past six months, after attempts to sell the company to Pfizer for $160bn
 Yahoo! Finance2 weeks ago
Reuters India

‘Superbugs’ force antibiotic clean-up

Thirteen leading drugmakers like Pfizer and GlaxoSmithKline on Tuesday have promised to curb the overuse of antibiotics and clean up pollution from factories making antibiotics as part of a drive to fight the rise of drug-resistant ‘superbugs.’ ...
 Asian Age1 month ago Drugmakers including Cipla, Wockhardt pledge to clean up antibiotic factories, curb overuse  Yahoo! Singapore1 month ago Drugmakers pledge to clean up antibiotic factories, curb overuse  Yahoo! News1 month ago

PFIZER : Drugmaker Opts to Sell Manhattan Properties -- WSJ

By Jonathan D. Rockoff Pfizer Inc., one of the world's biggest drug companies by sales, has told employees it will leave its longtime headquarters in Manhattan and look for a new office building in the borough, a spokeswoman said. The drugmaker ...
 4 Traders2 weeks ago Drugmaker Opts to Sell Manhattan Properties -- WSJ  ADVFN India2 weeks ago

Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva

September 20th, 2016 Xconomy New York — Millions of people in the U.S. suffer from chronic forms of pain, but the treatment options aren't great. Regeneron Pharmaceuticals is locked in a race with Eli Lilly and Pfizer to develop an ...
 Xconomy1 month ago Regeneron, Teva take aim at Lilly/Pfizer pain drug  Sharenet1 month ago REUTERS - Regeneron, Teva take aim at Lilly/Pfizer pain drug  Namibia Press Agency1 month ago

Pfizer, Genzyme deal with recalls over labeling issues

Labeling problems recently tripped up two big drugmakers, Pfizer and Genzyme, which are both recalling products after they discovered missing or incorrect expiration dates. In Pfizer's case, it is the second recall this year tied to a labeling ...
 FiercePharma3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less